Research Article

JNK Pathway Activation Is Controlled by Tao/TAOK3 to Modulate Ethanol Sensitivity

  • David Kapfhamer equal contributor mail,

    equal contributor Contributed equally to this work with: David Kapfhamer, Ian King (DK); (FWW)

    Affiliation: The Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America

  • Ian King equal contributor,

    equal contributor Contributed equally to this work with: David Kapfhamer, Ian King

    Affiliation: Department of Anatomy, Program in Neuroscience, University of California San Francisco, San Francisco, California, United States of America

    Current address: Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  • Mimi E. Zou,

    Affiliation: The Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America

  • Jana P. Lim,

    Affiliation: The Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America

    Current address: Department of Neuroscience, Stanford University, Palo Alto, California, United States of America

  • Ulrike Heberlein,

    Affiliations: The Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America, Department of Anatomy, Program in Neuroscience, University of California San Francisco, San Francisco, California, United States of America

    Current address: Janelia Farm Research Campus, Ashburn, Virginia, United States of America

  • Fred W. Wolf mail (DK); (FWW)

    Affiliation: The Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America

    Current address: School of Natural Sciences, University of California Merced, Merced, California, United States of America

  • Published: December 05, 2012
  • DOI: 10.1371/journal.pone.0050594


Neuronal signal transduction by the JNK MAP kinase pathway is altered by a broad array of stimuli including exposure to the widely abused drug ethanol, but the behavioral relevance and the regulation of JNK signaling is unclear. Here we demonstrate that JNK signaling functions downstream of the Sterile20 kinase family gene tao/Taok3 to regulate the behavioral effects of acute ethanol exposure in both the fruit fly Drosophila and mice. In flies tao is required in neurons to promote sensitivity to the locomotor stimulant effects of acute ethanol exposure and to establish specific brain structures. Reduced expression of key JNK pathway genes substantially rescued the structural and behavioral phenotypes of tao mutants. Decreasing and increasing JNK pathway activity resulted in increased and decreased sensitivity to the locomotor stimulant properties of acute ethanol exposure, respectively. Further, JNK expression in a limited pattern of neurons that included brain regions implicated in ethanol responses was sufficient to restore normal behavior. Mice heterozygous for a disrupted allele of the homologous Taok3 gene (Taok3Gt) were resistant to the acute sedative effects of ethanol. JNK activity was constitutively increased in brains of Taok3Gt/+ mice, and acute induction of phospho-JNK in brain tissue by ethanol was occluded in Taok3Gt/+ mice. Finally, acute administration of a JNK inhibitor conferred resistance to the sedative effects of ethanol in wild-type but not Taok3Gt/+ mice. Taken together, these data support a role of a TAO/TAOK3-JNK neuronal signaling pathway in regulating sensitivity to acute ethanol exposure in flies and in mice.


Alcohol is a highly popular psychoactive drug that humans have manufactured and consumed since prehistoric times. However, alcohol abuse is widespread and it imposes high social and monetary costs on society [1]. The efficacy of behavioral and medical interventions for alcohol abusers may be improved by understanding the basic biological mechanisms by which alcohol coopts normal body functions to lead to maladaptive behaviors. Previous studies demonstrated that a low level of response to the inebriating effects of alcohol is associated with an increased risk for developing alcohol use disorders [2], [3]. This implies that genes that govern responding to acute alcohol exposure may contribute to alcohol abuse. Understanding the genetic basis of the pharmacological actions of alcohol may thus provide new approaches to treatment of alcohol use disorders. The development of sophisticated assays that model aspects of alcoholism in genetically tractable organisms such as the mouse and the fruit fly Drosophila has greatly accelerated the identification of genes that impact alcohol responses, and some of these studies have led to preclinical and clinical trials for new treatments [4], [5], [6].

Mitogen activated protein kinases (MAPKs) comprise multi-tiered signal transduction cascades involved in sensing diverse extracellular stimuli including growth factors, cytokines and environmental stressors. MAPK activation induces changes in transcription, cellular morphology, differentiation, proliferation, and in cell death [7], [8]. Three partially overlapping MAPK pathways exist that are defined by the p38, extracellular signal regulated kinase (ERK), and c-jun N-terminal kinase (JNK) families [9], [10], [11].

Ethanol modulates MAPK signaling in multiple tissues, including the brain [9], [12], [13], [14]. In the fruit fly Drosophila and in mice, inhibition of the EGFR/ERK pathway increases sensitivity to ethanol-induced sedation [4], [15], and ERK also regulates ethanol sensitivity of the camouflage response in zebrafish [16], [17]. Chronic ethanol consumption and ethanol withdrawal induces ERK-dependent changes in synaptic plasticity in the rat dorsolateral striatum [18], and pharmacological inhibition of ERK signaling in mice can alter operant responding for ethanol [19]. Additionally, both ERK and JNK are activated in the basolateral amygdala in response to ethanol-associated cues [20]. Long-term exposure to ethanol can also induce JNK and p38 activity in the brain [21]. It is not known if the activity of either the JNK or the p38 pathway in the brain is functionally relevant for the behavioral effects of ethanol.

Drosophila tao promotes sensitivity to the locomotor stimulating effects of acute ethanol exposure [22]. tao encodes a serine-threonine kinase of the GCK-VIII subfamily of the Ste20p family, characterized by a highly conserved N-terminal kinase domain and a C-terminal region that regulates cytoskeletal dynamics [23], [24], [25], [26], [27], [28]. Fly TAO is homologous to mammalian TAOK1, TAOK2 and TAOK3 [23], [29], [30]. Cell culture experiments support a role for mammalian TAOK in MAPK signaling through the p38 and/or JNK pathways. All three TAOK proteins can activate p38 [31], [32], [33]. Further, JNK signaling can be activated by TAOK1 and TAOK2, whereas it can be inhibited by TAOK3 [23], [27], [30], [31].

To identify TAOK signaling pathways we searched for genetic interactions between fly TAO and key constituents of candidate MAPK pathways. Here we demonstrate that JNK is negatively regulated by TAO/TAOK3 in vivo, and we provide evidence for a neuronal role for JNK signaling in the behavioral effects of acute ethanol exposure. Support for these findings come from two evolutionarily divergent model organisms, the mouse and the fruit fly, suggesting that the relationship between TAO/TAOK3 and JNK in ethanol behavioral responses is conserved.

Materials and Methods

Ethics Statement

All animal protocols were approved by the Ernest Gallo Clinic and Research Center (EGCRC) Institutional Animal Care and Use Committee (approval number 09.11.197).

Drosophila Strains and Behavior

Flies were maintained on standard cornmeal/molasses/yeast media at 25°C and 70% relative humidity with an approximately 16 hr/8 hr light/dark schedule. Mutant strains were obtained from the NIG Kyoto Stock Center (pucNP1311), the Harvard Exelixis collection (bskEY01915), and the Bloomington Drosophila Stock Center. All strains were outcrossed for at least five generations to the w1118 Berlin genetic background. Behavior experiments used groups of 20 genetically identical male flies, and experiments were repeated on multiple days. Ethanol-induced locomotion assays were performed as described previously [34], [35]. Flies were exposed to 33% ethanol vapor (50:100 arbitrary flow units of ethanol:humidified air at a total flow of 5.5 L/min). Movies of ethanol-exposed flies were captured using QuickTime, and analyzed using a modified version of DIAS motion tracking software. The average speed of a population of 20 flies was determined at 14 intervals of 15 sec duration over the course of a 21 min exposure, and plotted versus time of exposure. Ethanol-induced locomotor activity was quantified as the area under the curve during the hyperactive phase. Ethanol absorption was measured in populations of 20 male flies, exposed to 33% ethanol vapor for 21 minutes. Flies were flash frozen, homogenized, and assayed for ethanol content using an alcohol dehydrogenase-based spectrophotometric assay (Diagnostic Chemicals, Ltd).

Drosophila Immunohistochemistry

Brains were dissected in PBS, fixed for 30 min at room temperature in PBS with 4% formaldehyde, washed twice in PBS with 0.3% triton X-100 (PBT), and blocked in PBT with 5% normal goat serum. Samples were incubated with primary antibody overnight, diluted as follows in PBT with 5% normal goat serum: anti-Fasciclin II 1:200 (1D4), anti-repo 1:10 (8D12, Developmental Studies Hybridoma Bank, Iowa), anti-GFP 1:1000 (Invitrogen), anti-TH 1:100 (Immunostar). After treatment with primary antibody, samples were washed three times in PBT and incubated overnight with fluorescently labeled secondary antibody diluted 1:500 (Molecular Probes). Samples were washed three times in PBT before mounting in Vectashield (Vector Labs).

Generation of Taok3 genetrap (Taok3Gt) Mice

C57BL/6J-derived blastocysts were injected with the RRK451 genetrap line ES cells, obtained from Bay Genomics (, according to standard protocols [36]. The genetrap line was generated on a 129/OlaHsd (agouti) background. Several chimeras were crossed to wild-type C57BL/6J mice and germline transmission of the targeted allele in progeny was confirmed by identifying agouti pups. Backcrosses of the resulting F1 mice (Taok3Gt129/+B6 X C57BL/6J) for 5 or more generations were done to generate Taok3Gt/+ heterozygous and wild-type controls for all studies, with two exceptions: studies to address the effects of SP600125 on ethanol consumption and clearance were performed on C57BL/6J mice obtained from Jackson Laboratory (Bar Harbor, ME), and locomotor stimulation experiments were performed on a C57BL/6J X 129/SvJ F1 background. Ethanol has been reported to weakly stimulate activity in C57BL/6J mice [37]. For this reason, Taok3GtB6/+B6 were crossed to 129/SvJ mice and the resulting F1 progeny were used for ethanol-induced locomotor stimulation experiments.

Mouse Genotypic Analysis

Mice were genotyped by PCR with DNA isolated from tail biopsies using standard protocols. The following primers were used to amplify a fragment of the genetrap insertion: (forward: 5′ TTATCGATGAGCGTGGTGGTTATGC-3′; reverse: 5′-GCGCGTACATCGGGCAAATAATATC-3′).

Quantitative RT-PCR (qPCR)

Total RNA was isolated from whole brain tissue using Trizol® reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions and was treated with RNase-free DNase (Promega, Madison, WI, USA) to remove genomic DNA contamination. cDNA was synthesized from 1 µg of total RNA using reverse transcription reagents from Applied Biosystems (Foster City, CA, USA). Following synthesis, cDNA was diluted 1:10 in water. TaqMan qPCR was performed using standard thermal cycling conditions on an ABI PRISM 7900 Sequence Detection System (Applied Biosystems). Amplification reactions contained 5 µl of cDNA template, 1× Universal PCR Master Mix, 100 nM each of forward and reverse primers, and 200 nM of FAM-labeled probe in a final volume of 10 µl. Taqman probesets used in this study were Taok3 (spanning exons 10–11): Mm001195800_m1, rodent Gapdh: 4352932E, Drosophila puc: Dm02135504_m1, Drosophila RpL32: Dm02151827_g1 (Applied Biosystems). Data were analyzed using the comparative CT method (Applied Biosystems user bulletin #2).

Protein Analysis

Protein extracts were derived from whole brain tissue in RIPA buffer containing phosphatase inhibitor (Sigma Aldrich, Inc., St. Louis, MO, USA) using standard techniques. For Western analysis, 10 µg protein samples were electrophoresed on NuPAGE 4–12% SDS-polyacrylamide gels (Invitrogen, Carlsbad, CA, USA) and transferred to PVDF membranes (Invitrogen). Primary antibodies were goat anti-TAOK3 (ab21205, ABCAM, Inc., Cambridge, MA) 1:1000, rabbit anti-phospho-JNK1+JNK2+JNK3 (ab76572, ABCAM, INC.) 1:1000, and mouse anti-GAPDH (Fisher Scientific, Pittsburgh, PA, USA), 1:5000. Western blots were incubated with HRP-linked donkey anti-goat (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), HRP-linked donkey anti-rabbit or HRP-linked sheep anti-mouse secondary antibody (GE Healthcare, Biosciences, Piscataway, NJ, USA), 1:10000, and processed with ECL Plus Western Blotting Detection System (GE Healthcare, Biosciences). Chemiluminescence was visualized and quantified using the Storm 660 phosphorimager system (Molecular Dynamics, Sunnyvale, CA, USA). For phospho-JNK experiments, wild-type and Taok3Gt/+ mice were treated with vehicle (0.9% saline) or 4 g/kg ethanol (20% v/v in saline) via intraperitoneal injection, 5 minutes prior to decapitation and dissection of brain tissue for protein extraction. 3 animals per experimental group were utilized.

Mouse Ethanol-induced Locomotor Stimulation

Mice for behavioral testing were bred in-house (Taok3Gt/+ and wild-type littermate controls) or obtained from the Jackson Laboratory (C57BL/6J mice for studies investigating the effects of SP600125 on ethanol clearance and consumption). Male mice were housed 3–5 per cage and were 10–14 weeks of age at the time of behavioral testing. Subjects were ethanol-naïve prior to each behavioral test.

Locomotor activity in response to ethanol was measured using 46×46 cm open field chambers (Med Associates, St. Albans, VT, USA). On the first day of testing, mice were allowed free access to the open field chambers for 1 hour, removed from the apparatus and administered a saline injection intraperitoneally, then returned to the chamber for an additional hour. On the second day of testing, the procedure was repeated with a 1 g/kg injection ethanol instead of saline. Horizontal distance traveled (in cm) was recorded in 5 minute bins for the duration of testing, with activity during the first 5 minutes post saline injection compared to activity during the first 5 minutes post ethanol injection.

Mouse Loss-of-righting Reflex (LORR)

Ethanol (10% v/v in saline) was administered intraperitoneally at a dose of 4 g/kg. After injection, mice were placed on their backs and tested for LORR. The mouse was judged to have lost the righting reflex at the time when it could not right itself three times within 30 sec. When the animal was able to right itself three times within 30 sec it was deemed to have recovered. The duration of the LORR was calculated as the difference between when the reflex was lost and when it was recovered. For pharmacological studies, inhibitor JNK II (SP600125, Anthra[1,9-cd]pyrazol-6(2H)-one, 1,9-pyrazoloanthrone, VWR, Radnor, PA, USA) was dissolved in 5%Tween 80/0.9% NaCl and injected subcutaneously at a dose of 5 mg/kg, 30 min prior to ethanol treatment. This dose was selected empirically based on previous studies [38], [39], [40], [41].

Mouse Ethanol Self-administration

Oral alcohol self-administration was examined using a limited access, drinking in the dark (DID) assay. One week prior to data collection, mice were singly housed and transferred to a reverse light-dark cycle. On day 8 of the experiment, water intake (ml) was measured for the 4-hour period beginning 4 hours after lights off and body weight (g) was recorded. Subsequently, mice were given access to a single bottle of 20% w/v ethanol during the same time of day, on alternate days for 12 days (6 days of ethanol access) and ethanol consumption was calculated. For pharmacological studies, subjects received a subcutaneous vehicle injection (Tween 80/0.9% NaCl) 10 min prior to ethanol availability on the first three days of ethanol access to acclimate subjects to injections. On subsequent ethanol access days subjects in the experimental group received a 5 mg/kg subcutaneous injection of inhibitor JNK II/Tween 80/0.9% NaCl, whereas control subjects continued to receive vehicle.

Mouse Ethanol Metabolism and Clearance

Mice were injected with 4 g/kg of ethanol and tail blood samples (10 µl) were obtained at 10, 30, 60, 120 and 180 minutes to measure blood alcohol levels. For pharmacological studies, subjects received a 5 mg/kg subcutaneous injection of inhibitor JNK II/Tween 80/0.9% NaCl or vehicle 30 min prior to ethanol treatment. Blood ethanol content was assessed from serum using the Analox AM1 Analyzer (Analox Instruments, North Yorkshire, UK).

Statistical Analysis

Data were analyzed using SigmaStat 3.1 (Systat Software, San Jose, CA, USA) or Prism (GraphPad, La Jolla CA). LORR data were analyzed by student’s t test. Ethanol consumption during DID experiments were analyzed by 2-way repeated-measures ANOVA for genotype X consumption (or JNK inhibitor treatment X consumption), followed by Newman-Keuls posthoc comparison. Similarly, ethanol clearance data were analyzed by 2-way repeated-measures ANOVA for genotype X time (or JNK inhibitor treatment X consumption), followed by Newman-Keuls posthoc comparison. mRNA and protein quantification in Taok3Gt/+ mice was normalized to control littermates and GAPDH signal and compared by student’s t test. Data are presented as mean ± standard error of the mean.


Mutation of JNK Pathway Genes Suppresses the Brain Structural Defects of tao Mutants

Because both fly tao and mouse Taok3 were identified as negative regulators of the JNK MAP kinase pathway signaling in cultured cells [23], [27], [30], [31], [42], we hypothesized that tao may act as a negative regulator of JNK signaling in the fly brain. Mutation of fly tao results in strong resistance to the locomotor stimulant properties of ethanol, and also results in highly penetrant structural defects in key neuropils of the central brain, including the mushroom bodies [22]. As a first test, we determined whether mutations in JNK pathway genes suppressed or enhanced the mushroom body structural defects of the loss of function allele taoEP1455, in which axons of mushroom body α/β neurons fail to form lobes [22], (Fig. 1A, D).


Figure 1. Mutations in bsk and hep suppress mushroom body morphology defects in tao mutants. A–F

, Anterior projections of whole-mount adult brains stained with anti-FasII. A, taoEP1455 hemizygous male brain. Asterisk marks mass of axons in the posterior brain characteristic of tao mutants. B, bsk1/bskJ27 male brain, with normal gross morphology of mushroom body α/β lobes. C, Double mutant taoEP1455; bsk1/bskJ27 male brain, with mushroom body α/β lobes indicated. D, taoEP1455/taoEP1455 homozygous female brain. E, hepr75/+, and F, taoEP1455+/taoEP1455 hepr75 female brains. Scale bars = 15 µm.


We examined the morphology of mushroom body α/β lobes in the brains of flies mutant for tao combined with loss-of-function alleles of the lone Drosophila JNK MAP kinase gene basket (bsk). Heterozygous hypomorphic bsk alleles had little to no effect on the mushroom body morphology defects in male flies hemizygous for taoEP1455 (data not shown). However, a viable combination of two hypomorphic alleles, bsk1/bskJ27, that did not affect mushroom body morphology (Fig. 1B), almost completely restored normal mushroom body morphology in taoEP1455 mutants (Fig. 1C). We further examined the brain morphology of these bsk mutants by immunostaining with anti-tyrosine hydroxylase (TH), which marks dopaminergic neurons, specific sets of which control ethanol-induced hyperactivity [43], and observed no defects in cell number or anatomical projection (data not shown). To confirm that the JNK pathway was responsible, we tested mutations in the upstream JNK MAPK kinase hemipterous (hep). For this test we used females because hemizygous strong loss-of-function mutations of the X-linked hep are lethal to males. Like hemizygous males, taoEP1455 homozygous females lack MB α/β lobes, displaying a “ball” of axons in the posterior of the brain near the MB calyx (Fig. 1D). We observed that heterozygotes for the null allele hepr75 had normal α/β lobe morphology (Fig. 1E), and that heterozygous hepr75 completely suppressed the mushroom body defects of homozygous taoEP1455 females (Fig. 1F). These results indicate that loss-of-function mutants in JNK pathway components can suppress the tao mushroom body morphology defect, and suggest that tao acts as a suppressor of JNK pathway signaling in the nervous system.

Mutations in the JNK MAPK Gene basket Affect Ethanol-induced Hyperactivity and Interact Genetically with tao

tao mutations result in strong resistance to the locomotor stimulant effects of acute ethanol exposure in flies [22]. To determine if decreased JNK signaling affects sensitivity to acute ethanol exposure, we tested male flies heterozygous for conventional loss-of function mutations in bsk [44], [45]. bsk1/+ flies showed normal ethanol-induced hyperactivity, but bskJ27/+ and bsk2/+ heterozygotes as well as flies heterozygous for bskEY01915, a P-element insertion in bsk that failed to complement the hypomorphic bsk1 allele for lethality displayed increased ethanol-induced hyperactivity (Fig. 2A–D), suggesting that reduced JNK signaling increased sensitivity to the locomotor stimulant effects of ethanol. These mutants showed normal kinetics of ethanol accumulation, indicating that the bsk phenotype is not due to altered ethanol absorption or metabolism (Fig. 2 legend).


Figure 2. Genetic interaction between tao and bsk.

A, Flies exposed to a continuous stream of ethanol vapor (black bar on x-axis) increase locomotor activity over time. A, bsk2/+ B, bskJ27/+ and C, bskEY01915/+ (“bskEY” is bskEY01915) mutants show enhanced ethanol-stimulated locomotion. Locomotor speed measured just prior to ethanol exposure is indicated at minute 1 for each graph. D, Quantification of traces in A–C, measured as the distance traveled during the hyperactive phase. E, Mutation of bsk suppressed the decreased ethanol-induced locomotor stimulation of taoEP1455 flies. F, bskEY01915 did not affect mushroom body morphology. Anterior projections of adult male wholemount brains stained with anti-FasII. α/β lobes are indicated. G, Lack of suppression of mushroom body structural defects in taoEP1455;bskEY01915/+ double mutant. Asterisk indicates posterior axon mass characteristic of taoEP1455 mutants. Ethanol absorption was unaltered in bsk mutants compared to the genetic background control strain (p = 0.5229, one-way ANOVA). Genotypes were compared using one-way ANOVA with Bonferroni correction. *p<0.05, **p<0.01, ***p<0.0001. Scale bars = 15 µm.


To test whether the negative genetic interaction between tao and JNK signaling extends to behavior, we assayed the effects of acute ethanol exposure on double mutant flies that were hemizygous for taoEP1455 and heterozygous for bskEY01915. The double mutant flies displayed increased ethanol-induced locomotion relative to flies singly mutant for tao (Fig. 2E), indicating that decreased JNK signaling was sufficient to restore normal hyperactivity to tao, and consistent with a negative regulatory interaction between tao and JNK signaling for ethanol behavior. Interestingly, heterozygous bskEY01915 did not suppress the MB morphology defect caused by taoEP1455 (Fig. 2F,G): these flies completely lacked MB α/β lobes. These data indicate that the increase in hyperactivity observed in the bsk mutant is independent of any structural effect on the MB and suggest that JNK signaling may be required in one or more brain loci that compensate for the loss of the MB α/β lobes caused by the taoEP1455 mutation.

JNK Phosphatase Puckered Promotes Ethanol-induced Hyperactivity

Our finding that bsk mutants exhibit increased sensitivity to the locomotor stimulant effects of acute ethanol exposure suggested that the JNK signaling pathway is important for this behavior. Expression of the MAPK phosphatase Puckered (Puc) is induced by Bsk activation, and subsequently Puc dephosphorylates and inactivates Bsk in a negative feedback loop [46], [47]. Consequently, loss of puc function increases JNK activation in response to upstream signals. Microarray studies indicate that puc expression is induced in response to acute ethanol exposure, with kinetics suggesting that the activation of the JNK pathway might play a role in ethanol-induced behavior [35].

To confirm ethanol-induction of puc transcription, we exposed wild-type male flies to ethanol vapor or air and measured puc RNA levels in whole head extracts using quantitative PCR analysis. We found that puc levels were increased approximately two-fold in ethanol-treated flies, consistent with activation of JNK signaling by acute ethanol exposure (Fig. 3A). We next tested whether decreased puc expression affected ethanol-induced hyperactivity. Flies heterozygous for puc1, a strong loss-of-function allele of puc, showed greatly reduced ethanol-induced hyperactivity (Fig. 3B,C), indicating that reduced puc activity and increased activation of the JNK pathway reduced this behavior, consistent with the increased hyperactivity observed in bsk mutants. As with bsk mutants, we examined brain morphology in puc1/+ flies using anti-FasII, and anti-TH staining, and observed no defects (Fig. 3D, data not shown). Further, puc1/+ flies had normal kinetics of ethanol accumulation (Fig. 3 legend). We conclude that increased JNK signaling decreases sensitivity to the locomotor stimulant properties of ethanol in Drosophila. While a developmental role for JNK signaling in ethanol-induced behavior cannot be ruled out, the induction of JNK pathway activity by ethanol exposure suggests that the pathway more directly modulates ethanol-induced behaviors.


Figure 3. puc is required in neurons for ethanol-induced locomotor stimulation.

A, Quantitative PCR detection of puc expression levels in fly head extracts following 30 min ethanol or air control exposure. **p = 0.0024 t test. B, Reduced ethanol-induced locomotor stimulation in puc1/+ flies. C, Quantification of traces shown in B. ***p<0.0001 t test. Ethanol absorption of puc1/+ was unaffected (p = 0.9607 t test). D, Mushroom body morphology of puc1/+ mutants was normal. Scale bar = 10 µm. E, Decreased ethanol-induced locomotor stimulation of puc1/+ mutants rescued by neuron-specific expression of puc. puc1/+ mutants carrying a UAS-puc transgene were crossed to the elavC155-Gal4 to restore puc expression levels specifically in neurons. F, elavC155-Gal4 did not increase ethanol-induced locomotor stimulation in puc1/+ mutants.


Neuronal Expression of puc Rescues Ethanol-induced Hyperactivity in puc Mutants

Tao activity is both necessary and sufficient in neurons in flies for increasing sensitivity to the locomotor stimulant properties of ethanol [22], and our results indicate that JNK signaling acts downstream of Tao. To investigate whether JNK acts in neurons to regulate ethanol responses, we used the Gal4-UAS heterologous expression system to test if neuron-specific expression of puc could rescue the ethanol phenotype of puc1/+ flies. We crossed flies carrying puc1 and a UAS-puc transgene to the pan-neuronal driver line elavC155-Gal4, and compared the ethanol-induced hyperactivity of the progeny to single-transgenic controls. We found that ethanol-induced hyperactivity was restored in puc1/+ mutants with elavC155-Gal4 and UAS-puc, showing that the behavioral defect of puc1/+ flies can be rescued with neuron-specific expression of puc (Fig. 3E). elavC155-Gal4 did not affect ethanol-induced hyperactivity of puc1/+ flies in the absence of the UAS-puc transgene, indicating that expression of Gal4 alone in neurons was not responsible for the rescue of the puc1/+ phenotype (Fig. 3F). Thus expression of puc solely in neurons is sufficient to promote ethanol-induced hyperactivity.

To define the site of action for puc for ethanol-induced hyperactivity, we examined the expression pattern of NP1311, a Gal4 enhancer trap transposon inserted in the third intron of the puc locus. We asked whether expression of puc specifically in this limited pattern was sufficient to rescue the behavioral phenotype of puc1/+ mutants. Flies heterozygous for NP1311 displayed normal levels of ethanol-induced hyperactivity, and restricted expression of puc in the NP1311 pattern was sufficient to restore ethanol-stimulated locomotion to control levels in puc1/+ mutants (Fig. 4A). These results indicate that puc expression in the pattern of NP1311 expression is sufficient to promote the locomotor stimulant properties of ethanol.


Figure 4. Expression pattern of a puc reporter line in the central brain.

A, Rescue of decreased puc1/+ ethanol-induced locomotor stimulation in the NP1311 expression pattern. Rescue genotypes were compared using one-way ANOVA with Bonferroni correction. *p<0.05, **p<0.01. B–K, Expression pattern of NP1311 puc enhancer trap detected with UAS-GFP. B, Confocal projection of the central brain, with NP1311 expression visualized with membrane-bound GFP (UAS-CD8.GFP, counterstained with NC82 to visualized neuropil. C, Projection showing mushroom body α/β and γ lobes, counterstained with anti-FasII. PI: pars intercerebralis. D, Projection showing lack of expression in the ellipsoid body (EB), counterstained with anti-FasII. E, NP1311 is neuron-specific. Individual cells in NP1311/+; UAS-nls.GFP/+ brains counterstained with anti-Repo to mark glia. F–K, NP1311 expression in dopaminergic neuron clusters. Arrowheads indicate cells with overlapping nls.GFP (green) and tyrosine hydroxylase (TH, magenta) staining. F, PPL1 cluster, G, PPL2, H, PAL, and I, PPM3. No overlap was observed in J, PPM1/2, or K, PAM. Scale bars = 20 µm (B), 10 µm (C,D), or 5 µm (E, F-K).


To define the expression pattern of NP1311, brains of NP1311/+;UAS-CD8.GFP/+ and NP1311/+;UAS-nls.GFP/+ flies were dissected and GFP expression visualized NP1311 drove GFP expression strongly in a number of adult brain loci, including the α/β neurons of the mushroom bodies (Fig. 4B,C). However, GFP expression was absent from neurons of the ellipsoid body, a brain region that is required to promote ethanol-stimulated locomotion [43], (Fig. 4D). Expression was seen in a number of dopaminergic neurons, including cells in the PPL1 (Fig. 4F), PPL2 (Fig. 4G), and PAL (Fig. 4H) clusters. Some expression was seen also in the PPM3 cluster (Fig. 4I), which also affects ethanol-induced locomotion. No expression was seen in the PPM1/2 (Fig. 4J) or PAM (Fig. 4K) dopaminergic clusters. No expression was observed in glia (Fig. 4E). The NP1311 enhancer trap likely captures a significant portion of the endogenous expression pattern of puc [48].

Disruption of Taok3 in Mice Alters Acute Sensitivity to Ethanol

Because tao interacts genetically with the JNK pathway and because JNK pathway activation affects ethanol-induced behavior in Drosophila we investigated whether these relationships were conserved in ethanol-dependent behaviors in mice. The Tao kinase family is represented in vertebrates by three orthologous genes, Taok1, Taok2 and Taok3 [24], [32]. Based on our observation that Drosophila tao interacts negatively with the JNK MAPK genes bsk and hep, we chose to investigate Taok3, the only TAOK that can inhibit JNK activity in cultured cells [30]. We generated Taok3 genetrap mice using the cell line RRK451 from the International Gene Trap Consortium ( This cell line contains a genetrap insertion in the eighth intron of the Taok3 gene and is predicted to result in a fusion transcript of exons 1–8 of Taok3 with the gene encoding β-galactosidase, truncating the endogenous Taok3 transcript within sequence encoding a portion of the kinase domain (Fig. 5A). Mice heterozygous for the Taok3 genetrap allele (Taok3Gt/+) were viable and normal in appearance. However, we failed to recover homozygous Taok3Gt/Gt mice, suggesting that disruption of both copies of Taok3 results in embryonic lethality and that the Taok3Gt allele may be hypomorphic or null.


Figure 5. Characterization of Taok3Gt/+ mice.

A, Schematic of the Taok3 locus with the genetrap insertion located between exons 8 and 9 of the gene. Exon numbers are indicated. “β geo” = β galactosidase/neomycin resistance markers within the genetrap insertion. B, Quantitative PCR data showing reduced Taok3 transcript in brain tissue of Taok3Gt/+ mice compared to controls. *p<0.05 t test. C, D, Western blot analysis of brain lysates from Taok3Gt/+ and wild-type control mice showing reduced TAOK3 protein levels in mutants. *p<0.05 t test. E, Taok3Gt/+ mice exhibit normal basal activity and locomotor stimulation in response to 1 g/kg ethanol. p = 0.27 ANOVA. F, Taok3Gt/+ mice are resistant to ethanol-induced sedation in the LORR assay following treatment with 4 g/kg ethanol. *p<0.05 t test. G, Ethanol absorption/clearance is unaffected by the Taok3Gt allele, BEC = blood ethanol content. p = 0.07, repeated measures ANOVA. H, Voluntary ethanol consumption is normal in Taok3Gt/+ mice. p = 0.85, repeated measures ANOVA.


To further characterize Taok3 gene disruption by the genetrap allele, we measured Taok3 transcript levels in brain tissue obtained from adult Taok3Gt/+ mice by quantitative PCR and observed a 40% reduction of endogenous Taok3 transcript (Fig. 5B). Similarly, we observed a 50% reduction in TAOK3 protein levels in brain tissue from Taok3Gt/+ mice by Western analysis (Fig. 5C,D), indicating that the genetrap insertion effectively disrupted the Taok3 gene. We also observed wild-type levels of TAOK1 and TAOK2 in brain tissue from Taok3Gt/+ mice (data not shown), indicating that disruption of one copy of the Taok3 gene did not result in compensatory changes in protein levels of TAOK1 or TAOK2.

Because disruption of the Drosophila tao gene strongly reduced the locomotor stimulant properties of acute ethanol exposure [22], we assessed the behavioral response of Taok3Gt/+ mice to ethanol in a battery of tests. We first assessed Taok3Gt/+ and wild-type control mice for hyperactivity induced by a 1 g/kg dose of ethanol. We observed a normal response (Fig. 5E), indicating that disruption of one copy of the Taok3 gene was not sufficient to affect ethanol-stimulated locomotion.

In contrast, when we tested Taok3Gt/+ mice in the loss-of-righting reflex (LORR) assay, a test of the sedative-hypnotic effects of ethanol, we observed a significant decrease in recovery time (Fig. 5F). We assessed ethanol metabolism/clearance of the same 4 g/kg dose ethanol in a drug-naïve group of animals and failed to detect a difference between genotypes (Fig. 5G), suggesting that the resistance of Taok3Gt/+ mice to the sedative properties of ethanol was not the result of altered ethanol pharmacokinetics.

Studies in humans and in rodent models suggested that initial sensitivity to ethanol may predict subsequent ethanol consumption [2], [49], [50], [51], [52], [53], [54], [55], [56]. However, using a limited access paradigm in which mice gained access to a single 20% w/v solution of ethanol for 4 hours during the dark or active phase of their circadian cycle, we did not detect a genotypic difference in ethanol consumption (Fig. 5H). Thus, reduction of Taok3 expression conferred resistance to the sedative effects of ethanol, but it did not alter ethanol consumption or ethanol-stimulated locomotion.

JNK is Negatively Regulated by TAOK3 in Mice and is Activated in the Brain by Ethanol

Mammalian cell culture experiments demonstrated that TAOK3 is a negative regulator of JNK activity; indeed, TAOK3 initially was named “JIK” for “JNK Inhibitor Kinase” [30]. To determine if TAOK3 inhibits JNK in vivo, we performed Western analysis using total brain extracts from Taok3Gt/+ and control mice. We found that phospho-JNK levels were constitutively increased in brains of Taok3Gt/+ mice, suggesting that TAOK3 negatively regulates JNK in vivo (Fig. 6A,B).


Figure 6. JNK activity is induced by ethanol

A, B. Western blot analysis of brain lysates from Taok3Gt/+ and wild-type control mice showing induction of phospho-JNK by ethanol in wild-type mice and increased phospho-JNK levels in brains of saline-treated Taok3Gt/+ mice relative to controls. *p<0.05 t test. Ethanol induction of phospho-JNK is occluded in Taok3Gt/+ mice.


JNK activity in the brain might also be regulated by ethanol exposure [21], [57], [58], [59], [60], [61], [62], [63], [64], [65]. We examined whether JNK activation was affected by treating mice with an acute, sedating dose of ethanol (4 g/kg). We observed an increase in phospho-JNK upon ethanol treatment in the brains of wild-type mice compared to saline-treated controls, indicating that acute ethanol treatment increased JNK activity in the brain (Fig. 6A,B). However, acute ethanol treatment did not increase the level of phospho-JNK in brains of Taok3Gt/+ mice relative to controls (Fig. 6A,B). Thus, while reduced TAOK3 levels increased constitutive JNK pathway activity in the brain, it prevented increased JNK activation that was elicited by acute ethanol exposure.

JNK Inhibition Confers Resistance to Ethanol-induced Sedation in Mice

Based on our data suggesting that TAOK3 promotes ethanol-induced sedation and that ethanol increases activated JNK in a TAOK3-dependent manner, we predicted that acute inhibition of the JNK pathway might affect ethanol-induced sedation. We tested this hypothesis by administering to wild-type mice 5 mg/kg of SP600125, which acts as a reversible ATP-competitive inhibitor of JNK MAP kinases [66], 30 minutes prior to the LORR assay. We found that SP600125 treatment conferred resistance to the sedating effects of ethanol in wild-type mice (Fig. 7A). In contrast, we found that SP600125 treatment failed to alter the duration of ethanol-induced sedation in Taok3Gt/+ mice (Fig. 7A). The same dose of JNK inhibitor did not alter clearance of 4 g/kg ethanol (Fig. 7B), suggesting that the effect of SP600125 on ethanol-induced sedation was not the result of altered ethanol pharmacokinetics. We subsequently tested whether SP600125 affected voluntary ethanol consumption in the limited access assay, but observed no significant effect of treatment (Fig. 7C).


Figure 7. JNK activity modulates behavioral sensitivity to ethanol in mice.

A, Pharmacological inhibition of JNK confers resistance to ethanol-induced sedation in wild-type but not Taok3Gt/+ mice. Mice were treated subcutaneously with vehicle or 5 mg/kg JNK inhibitor SP600125, 30 minutes prior to the LORR assay. **p<0.01, t test. B, SP600125 (5 mg/kg) does not alter ethanol pharmacokinetics. p = 0.94 repeated measures ANOVA. BEC = blood ethanol content. C, SP600125 (5 mg/kg) does not affect voluntary ethanol consumption. p = 0.73 repeated measures ANOVA. All mice received vehicle injections on days 1–3 before assignment to control or experimental groups.



We previously demonstrated that the Ste20 Kinase TAO was required in the fly brain for both establishing mushroom body structure and promoting sensitivity to the locomotor stimulant properties of acute ethanol exposure. We now show that 1) the TAO mouse homolog TAOK3 promotes sensitivity to acute ethanol sedation in mice, 2) both fly TAO and mouse TAOK3 inhibit JNK signaling in vivo, 3) JNK signaling affects behavioral responses to acute ethanol exposure in both flies and mice, 4) the role of JNK in ethanol behavior localizes to specific neurons in the fly brain, and 5) the mechanism by which the fly JNK gene bsk interacts with tao for ethanol behavior is independent of the role of tao in mushroom body structure. We propose that TAO/TAOK3 regulates JNK activity to promote sensitivity to the acute behavioral effects of ethanol. The role of JNK signaling in cell death induced by ethanol has been well documented: here we observe behavioral phenotypes in mutant flies at 2–4 fold lower ethanol concentrations and shorter exposures that do not result in cell death in Drosophila [67]. Recent cell culture and genetic interaction experiments allow us to propose a signaling framework for ethanol behavioral responses that includes TAO/TAOK3, JNK, and the kinase Par-1.

While manipulation of JNK pathway signaling caused ethanol-induced behavioral phenotypes in both flies and mice, the behaviors affected were different in these organisms. In Drosophila, JNK signaling may affect ethanol-induced locomotion specifically. A previous study did not detect changes in acute ethanol sedation sensitivity in flies that overexpressed wild-type, activated, and dominant negative JNK pathway proteins in the nervous system [4]. We similarly observed no effect on sedation sensitivity of the JNK pathway hypomorphic mutations (data not shown). Greater reductions in puc and bsk expression did result in altered ethanol sedation sensitivity, however these mutants also exhibited deficits in general locomotion, complicating the interpretation of ethanol behavioral phenotypes. RNAi directed against bsk has been reported to reduce sleep by increasing locomotion [68]. We believe, however, that the increase in ethanol-induced locomotion is mechanistically distinct, because in two of the three bsk alleles we tested we did not observe increased pre-exposure locomotor activity.

Conversely, mouse Taok3 mutants with constitutively activated JNK showed altered ethanol-induced sedation, but showed no effect on ethanol-induced locomotor activation. Acute disruption of JNK signaling in mice by the inhibitor SP600125 also affected ethanol-induced sedation, though we have not yet tested its effects on ethanol-induced locomotor activation. Gene family diversification may explain the species specific phenotypes: in mammals TAOK1 or TAOK2 may functionally compensate for TAOK3 with respect to ethanol-stimulated locomotion. As an initial test of this hypothesis, we observed unaltered ethanol-stimulated locomotion in mice in which both copies of the Taok2 gene were disrupted [69]. The analysis of compound Taok1/Taok2/Taok3 mutants may help clarify to what extent, if any, these genes are functionally redundant with respect to ethanol-stimulated locomotion. The JNK and other MAPK signaling pathway gene families also increase in complexity from flies to mice, such that additional positive and negative signaling activities may mask behaviorally relevant actions of specific JNK isoforms. Alternatively, the TAO/JNK signaling pathway may be used differently in different organisms.

We identified the MAPK phosphatase Puc as a key mediator of JNK pathway effects on ethanol-induced behavior in Drosophila. puc expression was induced upon ethanol exposure, decreased puc expression conferred resistance to the locomotor stimulating effects of ethanol, and the behavioral actions of puc localized to the nervous system. Importantly, puc expression induction indicates active JNK signaling [47], and is consistent with the increased phospho-JNK observed in the brains of ethanol treated mice. Combined with the behavioral phenotypes of bsk/JNK and hep/JNKK, the puc findings indicate that JNK activity normally promotes ethanol-stimulated locomotion in Drosophila. Puc is related to the DUSP family of mammalian MAPK phosphatases that are capable of dephosphorylating MAP kinases of all three families [70], [71], [72]. The modulation of JNK activity in mammals may be accomplished by multiple regulatory phosphatases in a more complex manner than in flies.

We also found that expression of Puc in a limited set of neurons is sufficient to promote sensitivity to the locomotor stimulant properties of ethanol. The expression pattern of the puc NP1311 Gal4 enhancer trap used for genetic rescue includes the MB α/β neurons, and the function of these neurons is required for promoting ethanol-stimulated locomotion [22]. However, bsk mutations can restore ethanol-induced hyperactivity in tao mutants lacking the MB α/β axon lobes, implying that the MB are not the primary locus at which JNK signaling affects ethanol-stimulated locomotion. Instead, JNK signaling may act in a separate neural locus that can compensate for function of the MB in this behavior. The R2/4 neurons of the ellipsoid body are also required for normal ethanol-stimulated locomotion [43], however these neurons are not included in the NP1311 expression pattern. The NP1311 pattern does encompass some dopaminergic neurons, including a small number of neurons in the PPM3 cluster, which are known to mediate ethanol-stimulated hyperactivity [43]. NP1311 also expresses strongly in neurons of the pars intercerebralis, which affect ethanol-induced sedation sensitivity [73]. However, the circuitry governing ethanol-induced behaviors is poorly defined, and more detailed mapping of the requirement for JNK signaling using newer Gal4 enhancer traps that more sparsely label the nervous system [74] will be necessary to resolve the loci of JNK activity that affect behavior in Drosophila.

In mice both pharmacological inhibition of the JNK pathway and a 50% reduction in Taok3 expression that increases activated JNK levels speeded recovery from ethanol-induced sedation. While these experiments clearly implicate JNK signaling in ethanol sensitivity in mice, a simple relationship between the level of activated JNK in the mouse brain and ethanol-induced sedation may not exist. However, Taok3 mutant mice also failed to increase levels of activated JNK upon exposure to ethanol. It may be, therefore, that ethanol-induced behavior is affected by the net increase in activated JNK level over baseline, rather than by its absolute level. Consistent with this idea is the observation that Taok3Gt/+ mice are resistant to the effects of SP600125 on ethanol-induced sedation and provides additional evidence that TAOK3 signals through JNK rather than parallel pathways to regulate ethanol-induced sedation. Alternatively, it is possible that Taok3 mutations specifically affect the activation state of particular JNK isoforms, while acute inhibition of all JNK isoforms by SP600125 has a different aggregate effect on behavior.

Repeated high level (binge) or chronic ethanol intake induces oxidative stress that is linked to tissue damage in organs including the liver, and it is well established that oxidative stress induces JNK signaling [75]. Similar ethanol exposure conditions can also lead to neuronal death through less well defined mechanisms that may include oxidative stress, excitotoxicity, or thiamine deficiency [76], [77]. The ethanol concentrations that resulted in tao/Taok3 and JNK pathway activation and behavioral phenotypes in mutants to a single acute exposure were too low to result in tissue damage [67], thus it is likely that a distinct JNK signaling mechanism is engaged. It remains possible, however, that acute ethanol exposure results in a neuronal oxidative stress response that is below the threshold for tissue damage, but that is sufficient to affect JNK signaling and behavior. Oxidative stress has been proposed to contribute to both normal synaptic development and synaptic plasticity [78]. Further, evidence in flies suggests that JNK signaling can affect both neuronal development and synaptic morphology [79], [80], [81].

Decreased Drosophila par-1 expression also suppresses the structural and ethanol behavioral phenotypes of tao mutants [22]. This raises the possibility that Par-1 and the JNK pathway may define a signaling pathway with TAO. Both Par-1 and JNK are implicated in the planar polarity (PP) pathway that controls oriented growth of cells in tissue morphogenesis [82], [83], [84]. The core constituents of the PP pathway also control multiple steps of neuronal development, including neurite outgrowth, axon pathfinding, and axon branching [85], [86], [87]. Accordingly, the PP pathway is required for the appropriate development of the Drosophila mushroom bodies [87]. Furthermore, behavioral roles were recently found for specific genes in the core PP pathway, including susceptibility to seizures and to social defeat stress [88], [89], and core PP pathway genes are expressed in the adult nervous system. Members of the TAO kinase family interact with both PAR-1 and the JNK pathway [23], [27], [30], [31], [90], however a direct connection of TAO kinases to the PP pathway has not been established. At a cellular level Par-1, TAO kinases, and the JNK pathway all regulate the structural dynamics of the cytoskeleton [91], [92], and may exert these effects through the microtubule binding protein Tau [22], [93], [94], [95]. Indeed, the cytoskeleton is markedly rearranged following acute ethanol exposure [96], [97]. Although we failed to detect gross morphological defects in brain structure of Taok3Gt/+ mice by immunohistological analysis (data not shown), we can not exclude the possibility that anomalies in brain morphology and/or neuronal connectivity underlie the ethanol sensitivity phenotype of these mice.


The authors thank Stacy Taylor, Eric C. Kong, and Willa Abrone for technical support, and Robert O. Messing and Dorit Ron for helpful discussions.

Author Contributions

Conceived and designed the experiments: DK IK UH FWW. Performed the experiments: DK IK MEZ JPL FWW. Analyzed the data: DK IK FWW. Wrote the paper: DK IK FWW.


  1. 1. Nutt DJ, King LA, Phillips LD (2010) Independent Scientific Committee on Drugs (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376: 1558–1565. doi: 10.1016/s0140-6736(10)61462-6
  2. 2. Schuckit MA (1994) Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151: 184–189.
  3. 3. Morean ME, Corbin WR (2010) Subjective response to alcohol: a critical review of the literature. Alcohol Clin Exp Res 34: 385–395. doi: 10.1111/j.1530-0277.2009.01103.x
  4. 4. Corl AB, Berger KH, Ophir-Shohat G, Gesch J, Simms JA, et al. (2009) Happyhour, a Ste20 family kinase, implicates EGFR signaling in ethanol-induced behaviors. Cell 137: 949–960. doi: 10.1016/j.cell.2009.03.020
  5. 5. Davies DL, Bortolato M, Finn DA, Ramaker MJ, Barak S, et al.. (2012) Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders. Alcohol Clin Exp Res. Doi:10.1111/j.1530-0277.2012.01846.x. [Epub ahead of print].
  6. 6. Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL (2012) Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharm (Berl) [Epub ahead of print].
  7. 7. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9: 726–735.
  8. 8. Krishna M, Narang H (2008) The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65: 3525–3544. doi: 10.1007/s00018-008-8170-7
  9. 9. Aroor AR, Shukla SD (2004) MAP kinase signaling in diverse effects of ethanol. Life Sci 74: 2339–2364. doi: 10.1016/j.lfs.2003.11.001
  10. 10. Kolch W, Calder M, Gilbert D (2005) When kinases meet mathematics: the systems biology of MAPK signaling. FEBS Lett 579: 1891–1895. doi: 10.1016/j.febslet.2005.02.002
  11. 11. Junttila MR, Li SP, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22: 954–965. doi: 10.1096/fj.06-7859rev
  12. 12. Ku BM, Lee YK, Jeong JY, Mun J, Han JY, et al. (2007) Ethanol-induced oxidative stress is mediated by p38 MAPK pathway in mouse hippocampal cells. Neurosci Lett 419: 64–67. doi: 10.1016/j.neulet.2007.03.049
  13. 13. Aroor AR, James TT, Jackson DE, Shukla SD (2010) Differential Changes in MAP Kinases, Histone Modifications, and Liver Injury in Rats Acutely Treated With Ethanol. Alcohol Clin Exp Res 34: 1543–1551. doi: 10.1111/j.1530-0277.2010.01239.x
  14. 14. Jung ME, Ju X, Simpkins JW, Metzger DB, Yan LJ, et al. (2010) Ethanol withdrawal acts as an age-specific stressor to activate cerebellar P38 kinase. Neurobiol Aging 32: 2266–2278. doi: 10.1016/j.neurobiolaging.2010.01.005
  15. 15. Eddison M, Guarnieri DJ, Cheng L, Liu CH, Moffat KG, et al. (2011) arouser reveals a role for synapse number in the regulation of ethanol sensitivity. Neuron 70: 979–990. doi: 10.1016/j.neuron.2011.03.030
  16. 16. Peng J, Wagle M, Mueller T, Mathur P, Lockwood BL, et al. (2009) Ethanol-modulated camouflage response screen in zebrafish uncovers a novel role for cAMP and extracellular signal-regulated kinase signaling in behavioral sensitivity to ethanol. J Neurosci 29: 8408–8418. doi: 10.1523/jneurosci.0714-09.2009
  17. 17. Wagle M, Mathur P, Guo S (2011) Corticotropin-releasing factor critical for zebrafish camouflage behavior is regulated by light and sensitive to ethanol. J Neurosci 31: 214–224. doi: 10.1523/jneurosci.3339-10.2011
  18. 18. Cui SZ, Wang SJ, Li J, Xie GQ, Zhou R, et al. (2011) Alteration of synaptic plasticity in rat dorsal striatum induced by chronic ethanol intake and withdrawal via ERK pathway. Acta Pharmacol Sin 32: 175–181. doi: 10.1038/aps.2010.199
  19. 19. Faccidomo S, Besheer J, Stanford PC, Hodge CW (2009) Increased operant responding for ethanol in male C57BL/6J mice: specific regulation by the ERK1/2, but not JNK, MAP kinase pathway. Psychopharmacology (Berl) 204: 135–147. doi: 10.1007/s00213-008-1444-9
  20. 20. Radwanska K, Wrobel E, Korkosz A, Rogowski A, Kostowski W, et al. (2008) Alcohol relapse induced by discrete cues activates components of AP-1 transcription factor and ERK pathway in the rat basolateral and central amygdala. Neuropsychopharmacology 33: 1835–1846. doi: 10.1038/sj.npp.1301567
  21. 21. Vallés SL, Blanco AM, Pascual M, Guerri C (2004) Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes. Brain Pathol 14: 365–371. doi: 10.1111/j.1750-3639.2004.tb00079.x
  22. 22. King I, Tsai LT, Pflanz R, Voigt A, Lee S, et al. (2011) Drosophila tao controls mushroom body development and ethanol-stimulated behavior through par-1. J Neurosci 31: 1139–1148. doi: 10.1523/jneurosci.4416-10.2011
  23. 23. Moore TM, Garg R, Johnson C, Coptcoat MJ, Ridley AJ, et al. (2000) PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization. J Biol Chem 275: 4311–4322. doi: 10.1074/jbc.275.6.4311
  24. 24. Dan I, Watanabe NM, Kusumi A (2001) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 11: 220–230. doi: 10.1016/s0962-8924(01)01980-8
  25. 25. Mitsopoulos C, Zihni C, Garg R, Ridley AJ, Morris JD (2003) The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability. J Biol Chem 278: 18085–18091. doi: 10.1074/jbc.m213064200
  26. 26. Timm T, Li XY, Biernat J, Jiao J, Mandelkow E, et al. (2003) MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J 22: 5090–5101. doi: 10.1093/emboj/cdg447
  27. 27. Zihni C, Mitsopoulos C, Tavares IA, Ridley AJ, Morris JD (2006) Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic morphology via C-Jun N-terminal kinase and Rho kinase-1. J Biol Chem 281: 7317–7323. doi: 10.1074/jbc.m513769200
  28. 28. Johne C, Matenia D, Li XY, Timm T, Balusamy K, et al. (2008) Spred1 and TESK1–two new interaction partners of the kinase MARKK/TAO1 that link the microtubule and actin cytoskeleton. Mol Biol Cell 19: 1391–1403. doi: 10.1091/mbc.e07-07-0730
  29. 29. Hutchison M, Berman KS, Cobb MH (1998) Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. J Biol Chem 273: 28625–28632. doi: 10.1074/jbc.273.44.28625
  30. 30. Tassi E, Biesova Z, Di Fiore PP, Gutkind JS, Wong WT (1999) Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor. J Biol Chem 274: 33287–33295. doi: 10.1074/jbc.274.47.33287
  31. 31. Chen Z, Cobb MH (2001) Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2. J Biol Chem 276: 16070–16075. doi: 10.1074/jbc.m100681200
  32. 32. Yustein JT, Xia L, Kahlenburg JM, Robinson D, Templeton D, et al. (2003) Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38. Oncogene 22: 6129–6141. doi: 10.1038/sj.onc.1206605
  33. 33. Yasuda S, Tanaka H, Sugiura H, Okamura K, Sakaguchi T, et al. (2007) Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases. Neuron 56: 456–471. doi: 10.1016/j.neuron.2007.08.020
  34. 34. Wolf FW, Rodan AR, Tsai LT, Heberlein U (2002) High-resolution analysis of ethanol-induced locomotor stimulation in Drosophila. J Neurosci 22: 11035–11044.
  35. 35. Kong EC, Allouche L, Chapot PA, Vranizan K, Moore MS, et al. (2010) Ethanol-regulated genes that contribute to ethanol sensitivity and rapid tolerance in Drosophila. Alcohol Clin Exp Res 34: 302–316. doi: 10.1111/j.1530-0277.2009.01093.x
  36. 36. Hogan B, Beddington R, Costantini F, Lacy E (1994) Manipulating the Mouse Embryo, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  37. 37. Downing C, Rodd-Hendricks KK, Flaherty L, Dudek BC (2003) Genetic analysis of the psychomotor stimulant effect of ethanol. Genes, Brain, Behav 2: 140–151. doi: 10.1034/j.1601-183x.2003.00022.x
  38. 38. Gao Y, Signore AP, Yin W, Cao G, Yin XM, et al. (2005) Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab 25: 694–712. doi: 10.1038/sj.jcbfm.9600062
  39. 39. Mitsuyama K, Tsuruta O, Matsui Y, Harada K, Tomiyasu N, et al. (2006) Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats. Clin Exp Immunol 143: 24–29. doi: 10.1111/j.1365-2249.2005.02959.x
  40. 40. Takamura M, Matsuda Y, Yamagiwa S, Tamura Y, Honda Y, et al. (2007) An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induc​edhepatic failure by modulating BH3-only proteins. Life Sci 80: 1335–1344. doi: 10.1016/j.lfs.2006.12.034
  41. 41. Nagata H, Hatano E, Tada M, Murata M, Kitamura K, et al. (2009) Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma. Hepatology 49: 1944–1953. doi: 10.1002/hep.22860
  42. 42. Bakal C, Linding R, Llense F, Heffern E, Martin-Blanco E, et al. (2008) Phosphorylation networks regulating JNK activity in diverse genetic backgrounds. Science 322: 453–456. doi: 10.1126/science.1158739
  43. 43. Kong EC, Woo K, Li H, Lebestky T, Mayer N, et al. (2010) A pair of dopamine neurons target the D1-like dopamine receptor DopR in the central complex to promote ethanol-stimulated locomotion in Drosophila. PLoS One 5: e9954. doi: 10.1371/journal.pone.0009954
  44. 44. Riesgo-Escovar JR, Jenni M, Fritz A, Hafen E (1996) The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye. Genes Dev 10: 2759–2768. doi: 10.1101/gad.10.21.2759
  45. 45. Sluss HK, Han Z, Barrett T, Goberdhan DC, Wilson C, et al. (1996) A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev 10: 2745–2758. doi: 10.1101/gad.10.21.2745
  46. 46. Glise B, Noselli S (1997) Coupling of Jun amino-terminal kinase and Decapentaplegic signaling pathways in Drosophila morphogenesis. Genes Dev 11: 1738–1747. doi: 10.1101/gad.11.13.1738
  47. 47. Martin-Blanco E, Gampel A, Ring J, Virdee K, Kirov N, et al. (1998) puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosophila. Genes Dev 12: 557–570. doi: 10.1101/gad.12.4.557
  48. 48. Rallis A, Moore C, Ng J (2010) Signal strength and signal duration define two distinct aspects of JNK-regulated axon stability. Dev Biol 339: 65–77. doi: 10.1016/j.ydbio.2009.12.016
  49. 49. Crabbe JC, Phillips TJ, Feller DJ, Hen R, Wenger CD, et al. (1996) Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet 14: 98–101. doi: 10.1038/ng0996-98
  50. 50. Naassila M, Ledent C, Daoust M (2002) Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J Neurosci 22: 10487–10493.
  51. 51. Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46: 243–253. doi: 10.1016/j.neuropharm.2003.09.002
  52. 52. Fee JR, Sparta DR, Knapp DJ, Breese GR, Picker MJ, et al. (2004) Predictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation. Alcohol Clin Exp Res 28: 1459–1468. doi: 10.1097/01.alc.0000141809.53115.71
  53. 53. Palmer AA, Sharpe AL, Burkhart-Kasch S, McKinnon CS, Coste SC, et al. (2004) Corticotropin-releasing factor overexpression decreases ethanol drinking and increases sensitivity to the sedative effects of ethanol. Psychopharmacology (Berl) 176: 386–397. doi: 10.1007/s00213-004-1896-5
  54. 54. Boyce-Rustay JM, Wiedholz LM, Millstein RA, Carroll J, Murphy DL, et al. (2006) Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res 30: 1957–1965. doi: 10.1111/j.1530-0277.2006.00241.x
  55. 55. Newton PM, Messing RO (2007) Increased sensitivity to the aversive effects of ethanol in PKCepsilon null mice revealed by place conditioning. Behav Neurosci 121: 439–442. doi: 10.1037/0735-7044.121.2.439
  56. 56. Kapfhamer D, Bettinger JC, Davies AG, Eastman CL, Smail EA, et al. (2008) Loss of RAB-3/A in Caenorhabditis elegans and the mouse affects behavioral response to ethanol. Genes Brain Behav 7: 669–776. doi: 10.1111/j.1601-183x.2008.00404.x
  57. 57. McAlhany RE Jr, West JR, Miranda RC (2000) Glial-derived neurotrophic factor (GDNF) prevents ethanol-induced apoptosis and JUN kinase phosphorylation. Brain Res Dev Brain Res 119: 209–216. doi: 10.1016/s0165-3806(99)00171-6
  58. 58. de la Monte SM, Ganju N, Banerjee K, Brown NV, Luong T, et al. (2000) Partial rescue of ethanol-induced neuronal apoptosis by growth factor activation of phosphoinositol-3-kinase. Alcohol Clin Exp Res 24: 716–726. doi: 10.1111/j.1530-0277.2000.tb02044.x
  59. 59. Pascaul M, Valles SL, Renau-Piqueras J, Guerri C (2003) Ceramide pathways modulate ethanol-induced cell death in astrocytes. J Neurochem 87: 1535–45. doi: 10.1046/j.1471-4159.2003.02130.x
  60. 60. Blanco AM, Vallés SL, Pascual M, Guerri C (2005) Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J Immunol 175: 6893–9.
  61. 61. Han JY, Jeong JY, Lee YK, Roh GS, Kim HJ, et al. (2006) Suppression of survival kinases and activation of JNK mediate ethanol-induced cell death in the developing rat brain. Neurosci Lett 398: 113–117. doi: 10.1016/j.neulet.2005.12.065
  62. 62. Han JY, Jeong EY, Kim YS, Roh GS, Kim HJ, et al. (2008) C-jun N-terminal kinase regulates the interaction between 14-3-3 and Bad in ethanol-induced cell death. J Neurosci Res 86: 3221–3229. doi: 10.1002/jnr.21759
  63. 63. Villegas SN, Njaine B, Linden R, Carri NG (2006) Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK signaling pathways. Brain Res Bull 71: 116–126. doi: 10.1016/j.brainresbull.2006.08.014
  64. 64. Young C, Straiko MM, Johnson SA, Creeley C, Olney JW (2008) Ethanol causes and lithium prevents neuroapoptosis and suppression of pERK in the infant mouse brain. Neurobiol Dis 31: 355–360. doi: 10.1016/j.nbd.2008.05.009
  65. 65. Ren J, Babcock SA, Li Q, Huff AF, Li SY, et al. (2009) Aldehyde dehydrogenase-2 transgene ameliorates chronic alcohol ingestion-induced apoptosis in cerebral cortex. Toxicol Lett 187: 149–156. doi: 10.1016/j.toxlet.2009.02.019
  66. 66. Bennett BL, Sasaki DT, Murray BW, O’Leary EC, Sakata ST, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98: 13681–13686. doi: 10.1073/pnas.251194298
  67. 67. French RL, Heberlein U (2009) Glycogen synthase kinase-3/Shaggy mediates ethanol-induced excitotoxic cell death of Drosophila olfactory neurons. Proc Natl Acad Sci U S A 106: 20924–20929. doi: 10.1073/pnas.0910813106
  68. 68. Takahama K, Tomita J, Ueno T, Yamazaki M, Kume S, et al. (2012) Pan-neuronal knockdown of the c-Jun N-terminal Kinase (JNK) results in a reduction in sleep and longevity in Drosophila. Biochem Biophys Res Commun 417: 807–811. doi: 10.1016/j.bbrc.2011.12.040
  69. 69. Kapfhamer D, Taylor S, Zou ME, Lim JP, Kharazia V, et al.. (2012) Taok2 controls behavioral response to ethanol in mice. Genes Brain Behav [Epub ahead of print].
  70. 70. Lang R, Hammer M, Mages J (2006) DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 177: 7497–7504. doi: 10.4049/jimmunol.177.11.7497
  71. 71. Jeffrey KL, Camps M, Rommel C, Mackay CR (2007) Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 6: 391–403. doi: 10.1038/nrd2289
  72. 72. Patterson KI, Brummer T, O’Brien PM, Daly RJ (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418: 475–489.
  73. 73. Corl AB, Rodan AR, Heberlein U (2005) Insulin signaling in the nervous system regulates ethanol intoxication in Drosophila melanogaster. Nat Neurosci 8: 18–19. doi: 10.1038/nn1363
  74. 74. Pfeiffer BD, Ngo TT, Hibbard KL, Murphy C, Jenett A, et al. (2010) Refinement of tools for targeted gene expression in Drosophila. Genetics 186: 735–755. doi: 10.1534/genetics.110.119917
  75. 75. Das SK, Vasudevan DM (2007) Alcohol-induced oxidative stress. Life Sci 81: 177–187. doi: 10.1016/j.lfs.2007.05.005
  76. 76. Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: From neuroadaptation to neurodegeneration. Progress in Neurobiology 56: 385–431. doi: 10.1016/s0301-0082(98)00032-x
  77. 77. Gibson GE, Zhang H (2002) Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem Int 40: 493–504. doi: 10.1016/s0197-0186(01)00120-6
  78. 78. Milton VJ, Sweeney ST (2012) Oxidative stress in synapse development and function. Dev Neurobiol 72: 100–110. doi: 10.1002/dneu.20957
  79. 79. Collins CA, Wairkar YP, Johnson SL, DiAntonio A (2006) Highwire restrains synaptic growth by attenuating a MAP kinase signal. Neuron 51: 57–69. doi: 10.1016/j.neuron.2006.05.026
  80. 80. Srahna M, Leyssen M, Choi CM, Fradkin LG, Noordermeer JN, et al. (2006) A signaling network for patterning of neuronal connectivity in the Drosophila brain. PLoS Biol 4: e348. doi: 10.1371/journal.pbio.0040348
  81. 81. Milton VJ, Jarrett HE, Gowers K, Chalak S, Briggs L, et al. (2011) Oxidative stress induces overgrowth of the Drosophila neuromuscular junction. Proc Natl Acad Sci U S A 108: 17521–17526. doi: 10.1073/pnas.1014511108
  82. 82. Weber U, Paricio N, Mlodzik M (2000) Jun mediates Frizzled-induced R3/R4 cell fate distinction and planar polarity determination in the Drosophila eye. Development 127: 3619–3629.
  83. 83. Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, et al. (2001) PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 3: 628–636.
  84. 84. Goodrich LV (2008) The plane facts of PCP in the CNS. Neuron 60: 9–16. doi: 10.1016/j.neuron.2008.09.003
  85. 85. Gao FB, Brenman JE, Jan LY, Jan YN (1999) Genes regulating dendritic outgrowth, branching, and routing in Drosophila. Genes Dev 13: 2549–2561. doi: 10.1101/gad.13.19.2549
  86. 86. Sanchez-Alvarez L, Visanuvimol J, McEwan A, Su A, Imai JH, et al. (2011) VANG-1 and PRKL-1 cooperate to negatively regulate neurite formation in Caenorhabditis elegans. PLoS Genet 7: e1002257. doi: 10.1371/journal.pgen.1002257
  87. 87. Ng J (2012) Wnt/PCP proteins regulate stereotyped axon branch extension in Drosophila. Development 139: 165–177. doi: 10.1242/dev.068668
  88. 88. Tao H, Manak JR, Sowers L, Mei X, Kiyonari H, et al. (2011) Mutations in prickle orthologs cause seizures in flies, mice, and humans. Am J Hum Genet 88: 138–149. doi: 10.1016/j.ajhg.2010.12.012
  89. 89. Wilkinson MB, Dias C, Magida J, Mazei-Robison M, Lobo M, et al. (2011) A novel role of the WNT-dishevelled-GSK3beta signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci 31: 9084–9092. doi: 10.1523/jneurosci.0039-11.2011
  90. 90. Wang JW, Imai Y, Lu B (2007) Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J Neurosci 27: 574–581. doi: 10.1523/jneurosci.5094-06.2007
  91. 91. Xia Y, Karin M (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 14: 94–101. doi: 10.1016/j.tcb.2003.12.005
  92. 92. Insolera R, Chen S, Shi SH (2011) Par proteins and neuronal polarity. Dev Neurobiol 71: 483–494. doi: 10.1002/dneu.20867
  93. 93. Biernat J, Wu YZ, Timm T, Zheng-Fischhofer Q, Mandelkow E, et al. (2002) Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell 13: 4013–4028. doi: 10.1091/mbc.02-03-0046
  94. 94. Sahara N, Murayama M, Lee B, Park JM, Lagalwar S, et al. (2008) Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation. Eur J Neurosci 27: 2897–2906. doi: 10.1111/j.1460-9568.2008.06258.x
  95. 95. Wetzel MK, Naska S, Laliberte CL, Rymar VV, Fujitani M, et al. (2008) p73 regulates neurodegeneration and phospho-tau accumulation during aging and Alzheimer’s disease. Neuron 59: 708–721. doi: 10.1016/j.neuron.2008.07.021
  96. 96. Offenhauser N, Castelletti D, Mapelli L, Soppo BE, Regondi MC, et al. (2006) Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics. Cell 127: 213–226. doi: 10.1016/j.cell.2006.09.011
  97. 97. King I, Heberlein U (2011) Tao kinases as coordinators of actin and microtubule dynamics in developing neurons. Commun Integr Biol 4: 554–556.